VC funding in digital health reaches $9.5B in 2018

It was a record-breaking year for global venture capital (VC) funding in digital health, with more than $9.5 billion raised in 698 deals for 2018, according to a report by Mercom Capital Group. The previous record was set last year, with $7.2 billion raised in 778 deals.

“Venture capital funding in digital health hit another high with almost $10 billion raised. Venture capitalists’ love of digital health companies is evident, but Wall Street is not yet convinced as more than 60 percent of publicly-traded digital health stocks traded below the S&P 500 in 2018,” Raj Prabhu, chief executive officer and co-founder of Mercom Capital Group, said in a prepared statement. “Funding deals every year have significantly outpaced (mergers and acquisitions) and IPO activity and exits continue to be a big challenge for digital health companies.”

Mobile health apps were among the highest-funded categories for 2018 with $1.3 billion raised. K-Health, a New York-based technology company, was among several companies apart of the trend. In December, K Health raised $25 million during a Series B funding round for its AI-powered health app that checks symptoms and provides information about a user’s health. In early 2018, the company raised $12.5 million for the platform during a venture funding round.

Highest-funded categories for 2018 also included:

  • Data Analytics with $2.1 billion,
  • Telemedicine with $1.1 billion
  • Mobile wireless technology companies with $847 million
  • Clinical decision support with $714 million
  • Wearable sensors technology companies with $703 million

The report also stated consumer-centric companies alone brought in $5.2 billion in 447 deals in 2018—a 24 percent rise in value from the $4.2 billion raised in 514 deals in 2017. Practice-centric companies raised about $4.3 billion in 251 deals in 2018, which was a 43 percent increase from the $3 billion raised in 264 deals in 2017.

Total corporate funding for digital health companies, including debt and public market financing, reached $13 billion in 2018, while debt and public market financing for digital health companies raised $3.5 billion in 21 deals in 2018.

In the United States alone, digital health companies raised close to $7 billion in 2018, with the remaining $2.5 billion coming from other countries, according to the report. Since 2010, digital health companies have received $35 billion in VC funding in more than 4,000 deals and almost $12 billion in debt and public market financing.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”